The Renal Protective Effect of Jiangya Tongluo Formula, through Regulation of Adrenomedullin and Angiotensin II, in Rats with Hypertensive Nephrosclerosis

<div>Histologic studies of JYTL in hypertensive nephrosclerosis rats after HE staining. (a) Control group. (b) Model group. (c) Valsartan group. (d) JYTL group. Bar = 200 <i>μ</i>m; same magnification for all panels. (a) The arrows point to the glomerular and the lined epithelia of renal tubules in normal condition. (b) Glomerular ischemia and sclerosis (blue arrow), interlobular artery with marked myointimal proliferation (yellow arrows), tubular atrophy and hyaline degeneration (little black arrow), and interstitial fibrosis with inflammatory cells hyperplasia (black arrow). (c) Interlobular artery mild-thickening with tubular vacuolar degeneration. (d) Tubular ectasia with hyaline degeneration. HE in 3-<i>μ</i>m thick sections, 200.</div>

Evidence-Based Complementary and Alternative Medicine

fig2

Figure 2

Figure 2: The Renal Protective Effect of Jiangya Tongluo Formula, through Regulation of Adrenomedullin and Angiotensin II, in Rats with Hypertensive Nephrosclerosis 

Figure 2 | The Renal Protective Effect of Jiangya Tongluo Formula, through Regulation of Adrenomedullin and Angiotensin II, in Rats with Hypertensive Nephrosclerosis 